Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
PLIANT THERAPEUTICS, INC. entered into Oyster Point Lease with HCP BTC, LLC valued at $0.26 million/month initial, $0.71 million/month final; 7 years; $1.43M letter of credit (effective 2023-09-28).
- Action
- entry
- Agreement
- lease
- Counterparty
- HCP BTC, LLC
- Value
- $0.26 million/month initial, $0.71 million/month final; 7 years; $1.43M letter of credit
- Effective
- 2023-09-28
Exact text from the filing
On September 28, 2023, Pliant Therapeutics, Inc., a Delaware Corporation (the “Company”) entered into a lease agreement (the “Oyster Point Lease”) with HCP BTC, LLC, a Delaware limited liability company (the “Landlord”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
PLIANT THERAPEUTICS, INC. terminated Littlefield Lease Termination with Healthpeak OP, LLC valued at Termination 60 days after Oyster Point Lease commencement; no penalty (effective 2023-09-28).
- Action
- termination
- Agreement
- lease
- Counterparty
- Healthpeak OP, LLC
- Value
- Termination 60 days after Oyster Point Lease commencement; no penalty
- Effective
- 2023-09-28
Exact text from the filing
In connection with the entry into the Oyster Point Lease, the Company entered into a termination agreement (the “Termination Agreement”) with Healthpeak OP, LLC, a Maryland limited liability company, successor-interest to HCP, Inc. (“Healthpeak”) with respect to the Company’s lease (the “Littlefield Lease”) of 260 Littlefield Avenue, South San Francisco, California 94080 (“Littlefield Premises”).
View on SEC.gov